Drug-drug Interaction Study Between UIC202304, and UIC202305
Clinical trial NCT07735052 · COMPLETED
Trial details
- NCT number
- NCT07735052
- Sponsor
- Korea United Pharm. Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-25
- Primary completion
- 2023-11-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.